Morten Graugaard Døssing

Director/Board Member at Precirix NV

Health Technology

Finance

Profile

Morten Graugaard Døssing currently works at Hoba Therapeutics ApS, as Director, Precirix NV, as Non Executive Director from 2018, and Novo Seeds, as Principal from 2016.

Morten Graugaard Døssing active positions

Companies	Position	Start
Novo Seeds Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark.	Private Equity Investor	2016-03-31
Hoba Therapeutics ApS Hoba Therapeutics ApS BiotechnologyHealth Technology Hoba Therapeutics ApS engages in research and experimental development in biotechnology. The firm’s purpose is commercialization of pharmaceuticals and biotechnology services. The company was founded on November 28, 2016 and is headquartered in Copenhagen, Denmark.	Director/Board Member	-
Precirix NV Precirix NV Pharmaceuticals: MajorHealth Technology Precirix NV develops and distributes radio-immunotherapeutic drugs for cancer patients. The company was founded on October 14, 2014 by Jens De Vos, Ludwig Camusot, Nick Devoogdt, Geert Raes, Tony Lahoutte and Matthias Dhuyvetter and is headquartered in Brussels, Belgium.	Director/Board Member	2018-10-31

All active positions of Morten Graugaard Døssing

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Morten Graugaard Døssing's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Novo Seeds Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark.	Finance
Hoba Therapeutics ApS Hoba Therapeutics ApS BiotechnologyHealth Technology Hoba Therapeutics ApS engages in research and experimental development in biotechnology. The firm’s purpose is commercialization of pharmaceuticals and biotechnology services. The company was founded on November 28, 2016 and is headquartered in Copenhagen, Denmark.	Health Technology
Precirix NV Precirix NV Pharmaceuticals: MajorHealth Technology Precirix NV develops and distributes radio-immunotherapeutic drugs for cancer patients. The company was founded on October 14, 2014 by Jens De Vos, Ludwig Camusot, Nick Devoogdt, Geert Raes, Tony Lahoutte and Matthias Dhuyvetter and is headquartered in Brussels, Belgium.	Health Technology

See company connections